Gentex Corp

GNTXNasdaqCIK 355811Consumer Cyclical / Auto Parts & Dealersfiscal year ends December70 quarters since 2009

Revenue, Q3 FY2026
$648M
−1.1% on Q3 FY2025
Net income
$91M
−10.3% on Q3 FY2025
Free cash flow
$64M
−42.4% on Q3 FY2025
Diluted EPS
$0.43
−6.5% on Q3 FY2025
Revenue, TTM
$2.6B
trailing four quarters
Net margin, TTM
15.1%
net income $397M
Free cash flow, TTM
$449M
$531M less $82M capex
Cash and equivalents
$136M
long-term debt —, Sep 30, 2026
Shares, 12-month change
−6.2%
205M shares, Sep 30, 2026
Buybacks, TTM
$358M
9.1% of market value
Dividends, TTM
$103M
2.6% of market value
Market value
$3.9B
at the close, buybacks

Latest quarter Q3 FY2026, filed November 6, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q3 FY2026, the quarter ended September 30, 2026, Gentex Corp reported revenue of $648M, −1.1% on Q3 FY2025, and net income of $91M (−10.3%). Operating margin was 17.8%. Free cash flow, operating cash flow less capital expenditures, was $64M ($84M less $20M). Diluted earnings per share were $0.43.

Share price

Daily candlesticks from November 18, 2024 to November 13, 2026, with each earnings release marked; a release after the close marks the day it came out, so its reaction is the next candle. See this earnings season for every company’s reaction.

GNTX daily priceSplit-adjusted, US dollars; an earnings release
Nov 13, 2026O $19.52 · H $19.67 · L $19.19 · C $19.20 · −0.88% on the dayOver the range: −17.53%, Nov 14, 2025 to Nov 13, 2026
$19$21$23$25$27Nov 25Jan 26Apr 26Jun 26Sep 26Nov 26

The last 16 quarters

Q4 FY2022 to Q3 FY2026, through the filing of November 6, 2026.

Revenue and net incomeRevenueNet income
$0$200M$400M$600M$800MQ4'22, Revenue: $494MQ4'22, Net income: $86MQ4'22Q1'23, Revenue: $551MQ1'23, Net income: $98MQ1'23Q2'23, Revenue: $583MQ2'23, Net income: $109MQ2'23Q3'23, Revenue: $576MQ3'23, Net income: $105MQ3'23Q4'23, Revenue: $589MQ4'23, Net income: $117MQ4'23Q1'24, Revenue: $590MQ1'24, Net income: $108MQ1'24Q2'24, Revenue: $573MQ2'24, Net income: $86MQ2'24Q3'24, Revenue: $609MQ3'24, Net income: $123MQ3'24Q4'24, Revenue: $542MQ4'24, Net income: $88MQ4'24Q1'25, Revenue: $577MQ1'25, Net income: $95MQ1'25Q2'25, Revenue: $658MQ2'25, Net income: $96MQ2'25Q3'25, Revenue: $655MQ3'25, Net income: $101MQ3'25Q4'25, Revenue: $644MQ4'25, Net income: $93MQ4'25Q1'26, Revenue: $675MQ1'26, Net income: $98MQ1'26Q2'26, Revenue: $651MQ2'26, Net income: $115MQ2'26Q3'26, Revenue: $648MQ3'26, Net income: $91MQ3'26$0$200M$400M$600M$800MQ4'22, Revenue: $494MQ4'22, Net income: $86MQ4'22Q1'23, Revenue: $551MQ1'23, Net income: $98MQ1'23Q2'23, Revenue: $583MQ2'23, Net income: $109MQ2'23Q3'23, Revenue: $576MQ3'23, Net income: $105MQ3'23Q4'23, Revenue: $589MQ4'23, Net income: $117MQ4'23Q1'24, Revenue: $590MQ1'24, Net income: $108MQ1'24Q2'24, Revenue: $573MQ2'24, Net income: $86MQ2'24Q3'24, Revenue: $609MQ3'24, Net income: $123MQ3'24Q4'24, Revenue: $542MQ4'24, Net income: $88MQ4'24Q1'25, Revenue: $577MQ1'25, Net income: $95MQ1'25Q2'25, Revenue: $658MQ2'25, Net income: $96MQ2'25Q3'25, Revenue: $655MQ3'25, Net income: $101MQ3'25Q4'25, Revenue: $644MQ4'25, Net income: $93MQ4'25Q1'26, Revenue: $675MQ1'26, Net income: $98MQ1'26Q2'26, Revenue: $651MQ2'26, Net income: $115MQ2'26Q3'26, Revenue: $648MQ3'26, Net income: $91MQ3'26$0$200M$400M$600M$800MQ4'22, Revenue: $494MQ4'22, Net income: $86MQ1'23, Revenue: $551MQ1'23, Net income: $98MQ1'23Q2'23, Revenue: $583MQ2'23, Net income: $109MQ3'23, Revenue: $576MQ3'23, Net income: $105MQ3'23Q4'23, Revenue: $589MQ4'23, Net income: $117MQ1'24, Revenue: $590MQ1'24, Net income: $108MQ1'24Q2'24, Revenue: $573MQ2'24, Net income: $86MQ3'24, Revenue: $609MQ3'24, Net income: $123MQ3'24Q4'24, Revenue: $542MQ4'24, Net income: $88MQ1'25, Revenue: $577MQ1'25, Net income: $95MQ1'25Q2'25, Revenue: $658MQ2'25, Net income: $96MQ3'25, Revenue: $655MQ3'25, Net income: $101MQ3'25Q4'25, Revenue: $644MQ4'25, Net income: $93MQ1'26, Revenue: $675MQ1'26, Net income: $98MQ1'26Q2'26, Revenue: $651MQ2'26, Net income: $115MQ3'26, Revenue: $648MQ3'26, Net income: $91MQ3'26

Net income losses drawn in red.

Free cash flow
$0$50M$100M$150M$200MQ4'22, Free cash flow: $64MQ4'22Q1'23, Free cash flow: $78MQ1'23Q2'23, Free cash flow: $73MQ2'23Q3'23, Free cash flow: $95MQ3'23Q4'23, Free cash flow: $107MQ4'23Q1'24, Free cash flow: $98MQ1'24Q2'24, Free cash flow: $97MQ2'24Q3'24, Free cash flow: $45MQ3'24Q4'24, Free cash flow: $113MQ4'24Q1'25, Free cash flow: $112MQ1'25Q2'25, Free cash flow: $135MQ2'25Q3'25, Free cash flow: $111MQ3'25Q4'25, Free cash flow: $100MQ4'25Q1'26, Free cash flow: $120MQ1'26Q2'26, Free cash flow: $165MQ2'26Q3'26, Free cash flow: $64MQ3'26$0$50M$100M$150M$200MQ4'22, Free cash flow: $64MQ4'22Q1'23, Free cash flow: $78MQ1'23Q2'23, Free cash flow: $73MQ2'23Q3'23, Free cash flow: $95MQ3'23Q4'23, Free cash flow: $107MQ4'23Q1'24, Free cash flow: $98MQ1'24Q2'24, Free cash flow: $97MQ2'24Q3'24, Free cash flow: $45MQ3'24Q4'24, Free cash flow: $113MQ4'24Q1'25, Free cash flow: $112MQ1'25Q2'25, Free cash flow: $135MQ2'25Q3'25, Free cash flow: $111MQ3'25Q4'25, Free cash flow: $100MQ4'25Q1'26, Free cash flow: $120MQ1'26Q2'26, Free cash flow: $165MQ2'26Q3'26, Free cash flow: $64MQ3'26$0$50M$100M$150M$200MQ4'22, Free cash flow: $64MQ1'23, Free cash flow: $78MQ1'23Q2'23, Free cash flow: $73MQ3'23, Free cash flow: $95MQ3'23Q4'23, Free cash flow: $107MQ1'24, Free cash flow: $98MQ1'24Q2'24, Free cash flow: $97MQ3'24, Free cash flow: $45MQ3'24Q4'24, Free cash flow: $113MQ1'25, Free cash flow: $112MQ1'25Q2'25, Free cash flow: $135MQ3'25, Free cash flow: $111MQ3'25Q4'25, Free cash flow: $100MQ1'26, Free cash flow: $120MQ1'26Q2'26, Free cash flow: $165MQ3'26, Free cash flow: $64MQ3'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$100M$200M$300MQ4'22, Cash and equivalents: $215MQ4'22Q1'23, Cash and equivalents: $215MQ1'23Q2'23, Cash and equivalents: $238MQ2'23Q3'23, Cash and equivalents: $261MQ3'23Q4'23, Cash and equivalents: $226MQ4'23Q1'24, Cash and equivalents: $249MQ1'24Q2'24, Cash and equivalents: $260MQ2'24Q3'24, Cash and equivalents: $180MQ3'24Q4'24, Cash and equivalents: $233MQ4'24Q1'25, Cash and equivalents: $287MQ1'25Q2'25, Cash and equivalents: $120MQ2'25Q3'25, Cash and equivalents: $179MQ3'25Q4'25, Cash and equivalents: $146MQ4'25Q1'26, Cash and equivalents: $165MQ1'26Q2'26, Cash and equivalents: $233MQ2'26Q3'26, Cash and equivalents: $136MQ3'26$0$100M$200M$300MQ4'22, Cash and equivalents: $215MQ4'22Q1'23, Cash and equivalents: $215MQ1'23Q2'23, Cash and equivalents: $238MQ2'23Q3'23, Cash and equivalents: $261MQ3'23Q4'23, Cash and equivalents: $226MQ4'23Q1'24, Cash and equivalents: $249MQ1'24Q2'24, Cash and equivalents: $260MQ2'24Q3'24, Cash and equivalents: $180MQ3'24Q4'24, Cash and equivalents: $233MQ4'24Q1'25, Cash and equivalents: $287MQ1'25Q2'25, Cash and equivalents: $120MQ2'25Q3'25, Cash and equivalents: $179MQ3'25Q4'25, Cash and equivalents: $146MQ4'25Q1'26, Cash and equivalents: $165MQ1'26Q2'26, Cash and equivalents: $233MQ2'26Q3'26, Cash and equivalents: $136MQ3'26$0$100M$200M$300MQ4'22, Cash and equivalents: $215MQ1'23, Cash and equivalents: $215MQ1'23Q2'23, Cash and equivalents: $238MQ3'23, Cash and equivalents: $261MQ3'23Q4'23, Cash and equivalents: $226MQ1'24, Cash and equivalents: $249MQ1'24Q2'24, Cash and equivalents: $260MQ3'24, Cash and equivalents: $180MQ3'24Q4'24, Cash and equivalents: $233MQ1'25, Cash and equivalents: $287MQ1'25Q2'25, Cash and equivalents: $120MQ3'25, Cash and equivalents: $179MQ3'25Q4'25, Cash and equivalents: $146MQ1'26, Cash and equivalents: $165MQ1'26Q2'26, Cash and equivalents: $233MQ3'26, Cash and equivalents: $136MQ3'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q3 FY2026 filed November 6, 2026.

Gentex Corp income statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Nov 6, 2026Q2 FY2026ended Jun 30, 2026filed Aug 4, 2026Q1 FY2026ended Mar 31, 2026filed May 6, 2026Q4 FY2025ended Dec 31, 2025filed Feb 24, 2026Q3 FY2025ended Sep 30, 2025filed Nov 7, 2025Q2 FY2025ended Jun 30, 2025filed Aug 8, 2025Q1 FY2025ended Mar 31, 2025filed May 6, 2025Q4 FY2024ended Dec 31, 2024filed Feb 25, 2025YoYQ3 FY2026vs Q3 FY2025
Revenue648651675644655658577542−1.1%
Cost of revenue431410447420430433385365+0.3%
Gross profit216241229225225225192176−3.9%
Research and development5249525353514647−2.0%
Selling, general and administrative4650505050493031−7.6%
Operating income11514112412012211911390−5.9%
Other income (expense)(8)(5)(6)(9)(2)(3)18−346.6%
Pretax income10713711811112111511498−11.1%
Income tax1723201820201910−15.4%
Net income911159893101969588−10.3%
Diluted EPS ($)0.430.540.46—0.460.430.420.39−6.5%
Diluted shares (millions)205209211—216220224——

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q3 FY2026 filed November 6, 2026.

Gentex Corp balance sheet, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Nov 6, 2026Q2 FY2026ended Jun 30, 2026filed Aug 4, 2026Q1 FY2026ended Mar 31, 2026filed May 6, 2026Q4 FY2025ended Dec 31, 2025filed Feb 24, 2026Q3 FY2025ended Sep 30, 2025filed Nov 7, 2025Q2 FY2025ended Jun 30, 2025filed Aug 8, 2025Q1 FY2025ended Mar 31, 2025filed May 6, 2025Q4 FY2024ended Dec 31, 2024filed Feb 25, 2025YoYQ3 FY2026vs Q3 FY2025
Cash and equivalents136233165146179120287233−23.6%
Short-term investments991055212122+91.6%
Total current assets1,1811,2311,2081,1281,1681,0621,0891,037+1.1%
Total assets2,9402,9992,9982,9292,9392,8142,7832,761+0.1%
Total current liabilities404405445388394337267253+2.5%
Long-term debt—————————
Total debt—————————
Total liabilities457458492438441381303289+3.5%
Stockholders’ equity——2,5032,4882,4952,4302,4752,468—
Shares outstanding (millions)205211213215219219225227—

Positions at each period end. Long-term debt is the line the filer tags, with or without its current portion. Total debt is one definition across filers, built from filed lines: long-term debt with its current portion plus short-term borrowings, finance leases where the filer folds them into its debt line, operating leases never; it is blank where the tags do not add up to it. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q3 FY2026 filed November 6, 2026.

Gentex Corp cash flow statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Nov 6, 2026Q2 FY2026ended Jun 30, 2026filed Aug 4, 2026Q1 FY2026ended Mar 31, 2026filed May 6, 2026Q4 FY2025ended Dec 31, 2025filed Feb 24, 2026Q3 FY2025ended Sep 30, 2025filed Nov 7, 2025Q2 FY2025ended Jun 30, 2025filed Aug 8, 2025Q1 FY2025ended Mar 31, 2025filed May 6, 2025Q4 FY2024ended Dec 31, 2024filed Feb 25, 2025YoYQ3 FY2026vs Q3 FY2025
Operating cash flow84185137125147166149154−42.8%
Capital expenditures2019172636313742−43.8%
Free cash flow (CFO − capex)64165120100111135112113−42.4%
Depreciation and amortization2626262526272624−1.0%
Share repurchases134696986301316821+343.2%
Dividends paid2526262626272727−4.0%

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed February 24, 2026.

Income statement

Gentex Corp income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 24, 2026FY2024ended Dec 31, 2024filed Feb 25, 2025FY2023ended Dec 31, 2023filed Feb 22, 2024FY2022ended Dec 31, 2022filed Feb 22, 2023FY2021ended Dec 31, 2021filed Feb 23, 2022FY2020ended Dec 31, 2020filed Feb 22, 2021FY2019ended Dec 31, 2019filed Feb 26, 2020FY2018ended Dec 31, 2018filed Feb 22, 2019FY2017ended Dec 31, 2017filed Feb 21, 2018FY2016ended Dec 31, 2016filed Feb 22, 2017FY2015ended Dec 31, 2015filed Feb 23, 2016FY2014ended Dec 31, 2014filed Feb 23, 2015FY2013ended Dec 31, 2013filed Feb 26, 2014FY2012ended Dec 31, 2012filed Feb 20, 2013FY2011ended Dec 31, 2011filed Feb 22, 2012FY2010ended Dec 31, 2010filed Feb 22, 2011FY2009ended Dec 31, 2009filed Aug 3, 2010FY2008ended Dec 31, 2008filed Aug 3, 2010
Revenue2,5342,3132,2991,9191,7311,6881,8591,8341,7951,6791,5441,3761,1721,1001,024816545624
Cost of revenue1,6681,5421,5371,3091,1111,0831,1711,1441,1001,010————————
Gross profit867771763610620605688690695668604539431373362296178203
Research and development203181154133118116115107100948884768582644752
Selling, general and administrative1781211131069290857571625756494849413642
Operating income47446049637041040048950852351245939930523423119195109
Other income (expense)(13)129071212148(1)516231513122(17)
Pretax income4614725053704164125005225325114644153282502442039692
Income tax76687751566476841251631451271058180663230
Net income3854044283193613484254384073483182892231691651386562
Diluted EPS ($)1.741.761.841.361.501.411.661.621.411.191.080.980.770.590.57*0.49*0.23*0.22*
Diluted shares (millions)218226230231237244253270288291296294289288289*281*275*—

Balance sheet

Gentex Corp balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 24, 2026FY2024ended Dec 31, 2024filed Feb 25, 2025FY2023ended Dec 31, 2023filed Feb 22, 2024FY2022ended Dec 31, 2022filed Feb 22, 2023FY2021ended Dec 31, 2021filed Feb 23, 2022FY2020ended Dec 31, 2020filed Feb 22, 2021FY2019ended Dec 31, 2019filed Feb 26, 2020FY2018ended Dec 31, 2018filed Feb 22, 2019FY2017ended Dec 31, 2017filed Feb 21, 2018FY2016ended Dec 31, 2016filed Feb 22, 2017FY2015ended Dec 31, 2015filed Feb 23, 2016FY2014ended Dec 31, 2014filed Feb 23, 2015FY2013ended Dec 31, 2013filed Feb 26, 2014FY2012ended Dec 31, 2012filed Feb 20, 2013FY2011ended Dec 31, 2011filed Feb 22, 2012FY2010ended Dec 31, 2010filed Feb 22, 2011FY2009ended Dec 31, 2009filed Aug 3, 2010FY2008ended Dec 31, 2008filed Aug 3, 2010
Cash and equivalents146233226215262423296217570546552497310390358348336294
Short-term investments522142352714016915317750061618617—
Total current assets1,1281,0379989498739799508511,1851,155984857601745752655505—
Total assets2,9292,7612,6112,3272,1312,1982,1692,0852,3522,3102,1492,0231,7641,2661,1761,003823—
Total current liabilities388253272251182178172169244150131133120881017259—
Long-term debt————————01782262582660————
Total debt————————01782262582660————
Total liabilities438289299261193234231224303399426451436145————
Stockholders’ equity2,4882,4682,3132,0661,9381,9641,9381,8622,0501,9101,7231,5711,3281,1211,027894736699
Shares outstanding (millions)215227231234236244251259274287289295291*286*288*285*——

Cash flow statement

Gentex Corp cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 24, 2026FY2024ended Dec 31, 2024filed Feb 25, 2025FY2023ended Dec 31, 2023filed Feb 22, 2024FY2022ended Dec 31, 2022filed Feb 22, 2023FY2021ended Dec 31, 2021filed Feb 23, 2022FY2020ended Dec 31, 2020filed Feb 22, 2021FY2019ended Dec 31, 2019filed Feb 26, 2020FY2018ended Dec 31, 2018filed Feb 22, 2019FY2017ended Dec 31, 2017filed Feb 21, 2018FY2016ended Dec 31, 2016filed Feb 22, 2017FY2015ended Dec 31, 2015filed Feb 23, 2016FY2014ended Dec 31, 2014filed Feb 23, 2015FY2013ended Dec 31, 2013filed Feb 26, 2014FY2012ended Dec 31, 2012filed Feb 20, 2013FY2011ended Dec 31, 2011filed Feb 22, 2012FY2010ended Dec 31, 2010filed Feb 22, 2011FY2009ended Dec 31, 2009filed Aug 3, 2010FY2008ended Dec 31, 2008filed Aug 3, 2010
Operating cash flow587498537338362464506552501477354327317258142128111121
Capital expenditures129145184146695285861041219873551171204721—
Free cash flow (CFO − capex)458354354192293413421466397356256255262140218190—
Depreciation and amortization10495939799105105102100898177635043393836
Share repurchases31520614711332528833159223116311130034000111
Dividends paid1071101121131151171161171091019788797367616160

Insider activity

Form 4 filings by officers, directors and 10% owners, November 16, 2024 to November 16, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$0
0 sales by 0 insiders; officers and directors $0
Bought, twelve months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, twelve months
$3M
13 sales by 9 insiders; officers and directors $3M

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
May 21, 2026Kennedy John CDirectoraward5,626$0.00—5,626May 22, 2026
May 21, 2026Zang LingDirectoraward5,626$0.00—35,599May 22, 2026
May 21, 2026Walker Brian CDirectoraward5,626$0.00—29,831May 22, 2026
May 21, 2026Starkoff KathleenDirectoraward5,626$0.00—36,770May 22, 2026
May 21, 2026Schaum Richard ODirectoraward5,626$0.00—87,069May 22, 2026
May 21, 2026Pink BillyDirectoraward5,626$0.00—15,329May 22, 2026
May 21, 2026Deur GarthDirectoraward5,626$0.00—20,045May 22, 2026
May 21, 2026Brown Leslie LDirectoraward5,626$0.00—41,988May 22, 2026
May 15, 2026Walker Brian CDirectoropen-market sale5,939$22.98$136K24,205May 15, 2026
May 15, 2026Anderson Joseph B JRDirectoropen-market sale5,939$22.98$136K0May 15, 2026
May 5, 2026Brown Leslie LDirectoroption exercise7,000$15.74$110K40,144May 5, 2026
May 5, 2026Brown Leslie LDirectoroption exercise7,000$18.70$131K47,144May 5, 2026
May 5, 2026Brown Leslie LDirectoropen-market sale10,782$22.85$246K36,362May 5, 2026
Apr 30, 2026Schaum Richard ODirectoroption exercise7,000$15.74$110K86,258Apr 30, 2026
Apr 30, 2026Schaum Richard ODirectoropen-market sale4,815$23.31$112K81,443Apr 30, 2026
Feb 19, 2026Boehm NeilChief Technology Officeraward14,953$0.00—73,904Feb 19, 2026
Feb 19, 2026Ryan Scott PGeneral Counselaward11,000$0.00—55,279Feb 19, 2026
Feb 19, 2026Nash Kevin CChief Financial Officeraward13,880$0.00—73,310Feb 19, 2026
Feb 19, 2026Downing Steven RPresident and CEOaward43,492$0.00—255,162Feb 19, 2026
Feb 19, 2026Chiodo MatthewVice President of Salesaward12,047$0.00—47,148Feb 19, 2026
Feb 17, 2026Boehm NeilChief Technology Officertax withholding3,608$24.89$90K61,283Feb 19, 2026
Feb 17, 2026Boehm NeilChief Technology Officeropen-market sale8,916$24.82$221K64,891Feb 19, 2026
Feb 17, 2026Boehm NeilChief Technology Officertax withholding14,160$24.89$352K73,807Feb 19, 2026
Feb 17, 2026Boehm NeilChief Technology Officeraward31,993$0.00—87,967Feb 19, 2026
Feb 17, 2026Boehm NeilChief Technology Officeropen-market sale2,332$24.82$58K58,951Feb 19, 2026

Full insider history for Gentex Corp, or insider activity across all companies. A record of filings, not a recommendation.

Tracked funds holding it

1 of the tracked managers held GNTX in their latest 13F filing, through November 12, 2026. Weight is the share of the fund’s reported portfolio. How the funds have traded GNTX by quarter.

FundManagerQuarterValueSharesWeightMove
Renaissance TechnologiesPeter BrownQ3 2026$38M2M0.05%added +4.8%

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
GENTEX CORPORATION, CIK 355811 on EDGAR
Extract generated
November 16, 2026
Withheld
none
Repaired
1 quarters where a full-year figure was filed in a quarter slot and the quarter was rebuilt: other income FY2022
XBRL concepts behind each line

Income statement

Revenue: RevenueFromContractWithCustomerExcludingAssessedTax, RevenueFromContractWithCustomerIncludingAssessedTax, SalesRevenueGoodsNet
Cost of revenue: CostOfGoodsAndServicesSold
Gross profit: GrossProfit
Research and development: ResearchAndDevelopmentExpense
Selling, general and administrative: SellingGeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): NonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: ShortTermInvestments
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebt
Total debt: LongTermDebt
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquireProductiveAssets
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfDividendsCommonStock

The data

The statements on this page as files, generated November 16, 2026.

JSON file
/data/financials/GNTX.json